Fonadelpar

CAS No. 515138-06-4

Fonadelpar( NPS-005 | SJP-0035 )

Catalog No. M14788 CAS No. 515138-06-4

Fonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1593 In Stock
50MG 3222 In Stock
100MG 4410 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fonadelpar
  • Note
    Research use only, not for human use.
  • Brief Description
    Fonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders.
  • Description
    Fonadelpar (NPS-005,SJP-0035) is a potent, selective peroxisome proliferator activated receptor δ (PPARδ) agonist for the treatment of corneal disorders.Other Indication Phase 2 Clinical.
  • In Vitro
    Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy.
  • In Vivo
    ——
  • Synonyms
    NPS-005 | SJP-0035
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    Other Indications
  • Indication
    Other Disease

Chemical Information

  • CAS Number
    515138-06-4
  • Formula Weight
    504.524
  • Molecular Formula
    C25H23F3N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)COC1=C(C)C=C2C(CCC3=C(C(C)C)N=C(C4=CC=C(C(F)(F)F)C=C4)S3)=NOC2=C1
  • Chemical Name
    2-[[5-methyl-3-[2-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]-1,2-benzoxazol-6-yl]oxy]acetic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MK-0533

    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.

  • GSK3787

    GSK3787 is as a selective and irreversible antagonist of PPARδ with pIC50 of 6.6, with no measurable affinity for hPPARα or hPPARγ.

  • Clofibrate

    Clofibrate (Atromid-S), a fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia.